USANA Health Sciences Inc (USNA)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 181,768 | 330,420 | 288,420 | 239,832 | 311,917 |
| Short-term investments | US$ in thousands | — | — | — | — | — |
| Receivables | US$ in thousands | 8,223 | 7,201 | 7,213 | 7,163 | 7,420 |
| Total current liabilities | US$ in thousands | 139,625 | 118,845 | 143,833 | 160,790 | 168,073 |
| Quick ratio | 1.36 | 2.84 | 2.06 | 1.54 | 1.90 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($181,768K
+ $—K
+ $8,223K)
÷ $139,625K
= 1.36
The quick ratio of USANA Health Sciences Inc has shown some fluctuations over the years. In 2020, the quick ratio was 1.90, indicating that the company had $1.90 of liquid assets to cover each dollar of current liabilities. By the end of 2021, the quick ratio decreased to 1.54, which could suggest a slight decrease in the company's ability to meet its short-term obligations with its most liquid assets.
However, the quick ratio improved significantly in 2022, reaching 2.06, and continued to strengthen in 2023 to 2.84. These higher ratios indicate that the company had a higher level of liquid assets relative to current liabilities, reflecting a potentially healthier financial position in terms of short-term liquidity.
Unfortunately, by the end of 2024, the quick ratio dropped to 1.36, signaling a potential decrease in the company's ability to cover its short-term obligations with its quick assets. Overall, while there were fluctuations, the company's quick ratio generally remained above 1, suggesting that USANA Health Sciences Inc has generally maintained a strong ability to meet its short-term obligations with its liquid assets.